Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 5
2013 8
2014 8
2015 11
2016 17
2017 15
2018 25
2019 24
2020 15
2021 5
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 33419944

109 results
Results by year
Filters applied: . Clear all
Page 1
QUANTIFICATION OF METASTATIC PROSTATE CANCER WHOLE-BODY TUMOR BURDEN WITH FDG PET PARAMETERS AND ASSOCIATIONS WITH OVERALL SURVIVAL AFTER FIRST LINE ABIRATERONE OR ENZALUTAMIDE: A SINGLE- CENTER RETROSPECTIVE COHORT STUDY.
Wibmer AG, Morris MJ, Gonen M, Zheng J, Hricak H, Larson SM, Scher HI, Vargas HA. Wibmer AG, et al. J Nucl Med. 2021 Jan 8:jnumed.120.256602. doi: 10.2967/jnumed.120.256602. Online ahead of print. J Nucl Med. 2021. PMID: 33419944
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y. Zhang H, et al. Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19. Acad Radiol. 2013. PMID: 22999369
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Liao S, Penney BC, Wroblewski K, Zhang H, Simon CA, Kampalath R, Shih MC, Shimada N, Chen S, Salgia R, Appelbaum DE, Suzuki K, Chen CT, Pu Y. Liao S, et al. Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):27-38. doi: 10.1007/s00259-011-1934-6. Epub 2011 Sep 23. Eur J Nucl Med Mol Imaging. 2012. PMID: 21946983
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223.
Bauckneht M, Capitanio S, Donegani MI, Zanardi E, Miceli A, Murialdo R, Raffa S, Tomasello L, Vitti M, Cavo A, Catalano F, Mencoboni M, Ceppi M, Marini C, Fornarini G, Boccardo F, Sambuceti G, Morbelli S. Bauckneht M, et al. Cancers (Basel). 2019 Dec 20;12(1):31. doi: 10.3390/cancers12010031. Cancers (Basel). 2019. PMID: 31861942 Free PMC article.
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
Caroli P, De Giorgi U, Scarpi E, Fantini L, Moretti A, Galassi R, Celli M, Conteduca V, Rossi L, Bianchi E, Paganelli G, Matteucci F. Caroli P, et al. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):348-354. doi: 10.1007/s00259-017-3866-2. Epub 2017 Nov 6. Eur J Nucl Med Mol Imaging. 2018. PMID: 29110067 Clinical Trial.
Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
Sharma A, Mohan A, Bhalla AS, Sharma MC, Vishnubhatla S, Das CJ, Pandey AK, Sekhar Bal C, Patel CD, Sharma P, Agarwal KK, Kumar R. Sharma A, et al. Clin Nucl Med. 2018 Jan;43(1):e8-e17. doi: 10.1097/RLU.0000000000001886. Clin Nucl Med. 2018. PMID: 29112011
Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.
Son SH, Lee SW, Jeong SY, Song BI, Chae YS, Ahn BC, Lee J. Son SH, et al. AJR Am J Roentgenol. 2015 Oct;205(4):878-85. doi: 10.2214/AJR.14.13906. Epub 2015 Jul 23. AJR Am J Roentgenol. 2015. PMID: 26204115
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
Woff E, Hendlisz A, Ameye L, Garcia C, Kamoun T, Guiot T, Paesmans M, Flamen P. Woff E, et al. J Nucl Med. 2019 Feb 1;60(2):178-184. doi: 10.2967/jnumed.118.210161. Epub 2018 Jun 29. J Nucl Med. 2019. PMID: 29959212 Free article.
Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Satoh K, Patel D, Dieckmann W, Nilubol N, Kebebew E. Satoh K, et al. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S714-20. doi: 10.1245/s10434-015-4813-8. Epub 2015 Aug 18. Ann Surg Oncol. 2015. PMID: 26282908
Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
Calles-Sastre L, Mucientes-Rasilla J, San-Frutos Llorente LM, Royuela A, Garcia-Espantaleón Navas M, Herrero Gámiz S, Pérez-Medina T. Calles-Sastre L, et al. Rev Esp Med Nucl Imagen Mol. 2019 Jan-Feb;38(1):17-21. doi: 10.1016/j.remn.2018.08.001. Epub 2018 Oct 23. Rev Esp Med Nucl Imagen Mol. 2019. PMID: 30366731 English, Spanish.
109 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page